Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis

Autor: Payne, Amanda B ^*, Watts, Janet A, Mitchell, Patrick K, Dascomb, Kristin, Irving, Stephanie A, Klein, Nicola P, Grannis, Shaun J, Ong, Toan C, Ball, Sarah W, DeSilva, Malini B, Natarajan, Karthik, Sheffield, Tamara, Bride, Daniel, Arndorfer, Julie, Naleway, Allison L, Koppolu, Padma, Fireman, Bruce, Zerbo, Ousseny, Timbol, Julius, Goddard, Kristin, Dixon, Brian E, Fadel, William F, Rogerson, Colin, Allen, Katie S, Rao, Suchitra, Mayer, David, Barron, Michelle, Reese, Sarah E, Rowley, Elizabeth A K, Najdowski, Morgan, Ciesla, Allison Avrich, Mak, Josephine, Reeves, Emily L, Akinsete, Omobosola O, McEvoy, Charlene E, Essien, Inih J, Tenforde, Mark W, Fleming-Dutra, Katherine E, Link-Gelles, Ruth

Publikováno v: In The Lancet 19-25 October 2024 404(10462):1547-1559

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022.

Autor: DeSilva MB; HealthPartners Institute, Minneapolis, Minnesota, USA., Mitchell PK; Westat, Rockville, Maryland, USA., Klein NP; Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California, USA., Dixon BE; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.; Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA., Tenforde MW; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Thompson MG; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Naleway AL; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA., Grannis SJ; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.; School of Medicine, Indiana University, Indianapolis, Indiana, USA., Ong TC; School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Natarajan K; Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York, USA.; New York Presbyterian Hospital, New York, New York, USA., Reese SE; Westat, Rockville, Maryland, USA., Zerbo O; Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California, USA., Kharbanda AB; Children's Minnesota, Minneapolis, Minnesota, USA., Patel P; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Stenehjem E; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, USA., Raiyani C; Baylor Scott and White Health, Temple, Texas, USA., Irving SA; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA., Fadel WF; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.; Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA., Rao S; School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Han J; Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York, USA., Reynolds S; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Davis JM; Westat, Rockville, Maryland, USA., Lewis N; Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California, USA., McEvoy C; HealthPartners Institute, Minneapolis, Minnesota, USA., Dickerson M; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Dascomb K; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, USA., Valvi NR; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA., Barron MA; School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Goddard K; Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California, USA., Vazquez-Benitez G; HealthPartners Institute, Minneapolis, Minnesota, USA., Grisel N; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, USA., Mamawala M; Baylor Scott and White Health, Temple, Texas, USA., Embi PJ; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Fireman B; Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California, USA., Essien IJ; HealthPartners Institute, Minneapolis, Minnesota, USA., Griggs EP; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Arndorfer J; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, USA., Gaglani M; Baylor Scott and White Health, Temple, Texas, USA.; Texas A&M University College of Medicine, Temple, Texas, USA.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2023 Apr 18; Vol. 227 (8), pp. 961-969.